Additive interactions between retigabine and oxcarbazepine in the chimney test and the model of generalized tonic-clonic seizures in mice

Berenbaum M.C.:What is synergy? Pharmacological Reviews, 1989, 41: 93–141.10.1111/j.0033-0124.1989.00093.xSearch in Google Scholar

Boissier J.R., Tardy J., Diverres J.C.:Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminée. Pharmacology, 1960, 3: 81–84.10.1159/000134913Search in Google Scholar

Brodie M.J., Sills G.J.:Combining antiepileptic drugs-rational polytherapy? Seizure, 2011, 20: 369–375.10.1016/j.seizure.2011.01.004Search in Google Scholar

Czapiński P., Błaszczyk B., Czuczwar S.J.:Mechanisms of action of antiepileptic drugs. Current Topics in Medical Chemistry, 2005, 5: 3–14.10.2174/1568026053386962Search in Google Scholar

Deckers C.L., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H. et al.:Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia, 2000, 41: 1364–1374.10.1111/j.1528-1157.2000.tb00111.xSearch in Google Scholar

European Medicines Agency:Trobalt: EPAR – Product Information. 2016 (http://www.ema.europa.eu/ema/index. jsp?curl=pages/medicines/human/medicines/001245/human_med_001431.jsp&mid=WC0b01ac058001d124) [accessed 08 NOV 2016].Search in Google Scholar

Gessner P.K.:Isobolographic analysis of interactions: an update on applications and utility. Toxicology, 1995, 105: 161–179.10.1016/0300-483X(95)03210-7Search in Google Scholar

Kondrat-Wróbel M.W., Łuszczki J.J.:Interaction of three-drug combination of lacosamide, carbamazepine and phenobarbital in the mouse maximal electroshock-induced seizure model – an isobolographic analysis. Health Problems of Civilization, 2016, 10: 55–61.10.5114/hpc.2016.58209Search in Google Scholar

Kwan P., Brodie M.J.:Combination therapy in epilepsy: when and what to use. Drugs, 2006, 66: 1817–1829.10.2165/00003495-200666140-00004Search in Google Scholar

Kwan P., Schachter S.C., Brodie M.J.:Drug-resistant epilepsy. The New England Journal of Medicine, 2011, 365: 919–926.10.1056/NEJMra1004418Search in Google Scholar

Lerche H., Daniluk J., Lotay N., DeRossett S., Edwards S., Brandt C.:Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures. Seizure, 2015, 30: 93–100.10.1016/j.seizure.2015.06.002Search in Google Scholar

Litchfield J.T. Jr., Wilcoxon F.:A simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics, 1949, 96: 99–113.Search in Google Scholar

Löscher W., Fassbender C.P., Nolting B.:The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Research, 1991, 8: 79–94.10.1016/0920-1211(91)90075-QSearch in Google Scholar

Löscher W., Nolting B.:The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Research, 1991, 9: 1–10.10.1016/0920-1211(91)90041-DSearch in Google Scholar

Łuszczki J.J., Andres M.M., Czuczwar P., Cioczek-Czuczwar A., Ratnaraj N., Patsalos P.N. et al.:Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Epilepsia, 2006, 47: 10–20.10.1111/j.1528-1167.2006.00364.x16417526Search in Google Scholar

Łuszczki J.J., Andres M.M., Czuczwar S.J.:Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model-an isobolographic analysis. European Journal of Pharmacology, 2005a, 515: 54–61.10.1016/j.ejphar.2005.03.04615894310Search in Google Scholar

Łuszczki J.J., Antkiewicz-Michaluk L., Raszewski G., Czuczwar S.J.:Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis. Epilepsy Research, 2010a, 89: 207–219.10.1016/j.eplepsyres.2010.01.00120117917Search in Google Scholar

Łuszczki J.J., Borowicz K.K., Świąder M., Czuczwar S.J.:Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia, 2003, 44: 489–499.10.1046/j.1528-1157.2003.32702.x12680997Search in Google Scholar

Łuszczki J.J., Czuczwar S.J.:Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics – a comparative study. Epilepsy Research, 2003, 56: 27–42.10.1016/j.eplepsyres.2003.08.00314529951Search in Google Scholar

Łuszczki J.J., Czuczwar S.J.:Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia, 2004, 45: 895–907.10.1111/j.0013-9580.2004.05104.x15270754Search in Google Scholar

Łuszczki J.J., Czuczwar, S.J.:Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis. European Neuropsychopharmacology, 2005, 15: 133–142.10.1016/j.euroneuro.2004.06.00215695057Search in Google Scholar

Łuszczki J.J., Filip D., Czuczwar S.J.:Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. Epilepsy Research, 2010b, 91: 166–175.10.1016/j.eplepsyres.2010.07.00920692123Search in Google Scholar

Łuszczki J.J., Ratnaraj N., Patsalos P.N., Czuczwar S.J.:Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model. Epilepsia, 2005b, 46: 344–355.10.1111/j.0013-9580.2005.34704.x15730531Search in Google Scholar

Łuszczki J.J., Wu J.Z., Raszewski G., Czuczwar S.J.:Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. Naunyn-Schmiedebergs Archives of Pharmacology, 2009, 379: 163–179.10.1007/s00210-008-0349-918773196Search in Google Scholar

Łuszczki J.J., Zagaja M., Miziak B., Florek-Łuszczki M., Czuczwar S.J.:Synergistic interaction of retigabine with levetiracetam in the mouse maximal electroshock-induced seizure model: a type II isobolographic analysis. Pharmacology, 2015, 96: 11–15.10.1159/00043082226045245Search in Google Scholar

Łuszczki J.J.:Interaction of pregabalin with carbamazepine in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. Advances in Medical Sciences, 2010, 55: 43–52.10.2478/v10039-010-0005-820371433Search in Google Scholar

Łuszczki J.J.:Isobolographic analysis of interaction for three-drug combination of carbamazepine, phenobarbital and topiramate in the mouse maximal electroshock-induced seizure model. Pharmacology, 2016, 97: 259–264.10.1159/00044445226910763Search in Google Scholar

Perucca E.:Clinically relevant drug interactions with antiepileptic drugs. British Journal of Clinical Pharmacology, 2006, 61: 246–255.10.1111/j.1365-2125.2005.02529.x188502616487217Search in Google Scholar

Perucca E.:Pharmacological principles as a basis for polytherapy. Acta Neurologica Scandinavica, Suppl., 1995, 162: 31–34.10.1111/j.1600-0404.1995.tb00497.x7495187Search in Google Scholar

Rejdak K., Łuszczki J.J., Błaszczyk B., Chwedorowicz R., Czuczwar S.J.:Clinical utility of adjunctive retigabine in partial onset seizures in adults. Therapeutics and Clinical Risk Management, 2012, 8: 7–14.10.2147/TCRM.S22605326934622298949Search in Google Scholar

Rundfeldt C., Netzer R.:Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels. Arzneimittelforschung, 2000, 50: 1063–1070.10.1055/s-0031-130034611190770Search in Google Scholar

Tallarida R.J.:Quantitative methods for assessing drug synergism. Genes Cancer, 2011, 2: 1003–1008.10.1177/1947601912440575337956422737266Search in Google Scholar

Tallarida R.J.:Revisiting the isobole and related quantitative methods for assessing drug synergism. Journal of Pharmacology and Experimental Therapeutics, 2012, 342: 2–8.10.1124/jpet.112.193474338303622511201Search in Google Scholar

Tompson D.J., Crean C.S.:The interaction potential of retigabine (ezogabine) with other antiepileptic drugs. Current Clinical Pharmacology, 2014, 9: 148–156.10.2174/157488470866613111119231124219007Search in Google Scholar

Treven M., Koenig X., Assadpour E., Gantumur E., Meyer C., Hilber K. et al.:The anticonvulsant retigabine is a subtype selective modulator of GABA_A receptors. Epilepsia, 2015, 56: 647–657.10.1111/epi.12950494965125779225Search in Google Scholar

Żółkowska D., Zagaja M., Miziak B., Kondrat-Wróbel M.W., Załuska K., Florek-Łuszczki M. et al.:Isobolographic assessment of interactions between retigabine and phenytoin in the mouse maximal electroshock-induced seizure model and chimney test. Health Problems of Civilization, 2016, 10: 54–59.10.5114/hpc.2016.63572Search in Google Scholar